Filing Details
- Accession Number:
- 0001140361-13-038748
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-15 20:17:25
- Reporting Period:
- 2013-10-10
- Filing Date:
- 2013-10-15
- Accepted Time:
- 2013-10-15 20:17:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-10-10 | 3,000 | $66.76 | 45,740 | No | 4 | S | Indirect | Shares held by Bienaime Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Shares held by Bienaime Family Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,000 | Indirect | Held in irrevocable trust for Guillaume Bienaime |
| Common Stock | 10,000 | Indirect | Held in irrevocable trust for Pierre Bienaime |
| Common Stock | 10,000 | Indirect | Held in irrevocable trust for Paul Bienaime |
| Common Stock | 10,000 | Indirect | Held in irrevocable trust for Marc Bienaime |
| Common Stock | 20,000 | Indirect | Held in irrevocable trust for Aurelie Mitsuki Bienaime and Anais Kimiko |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 trading plan executed on August 9, 2013.
- The price in column 4 is a weighted average price. The price actually received ranged from $65.72 to $67.99. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at eachprice within the range.
- The reporting person and his spouse act as trustees for the Bienaime Family Trust.
- The reporting person's spouse is trustee of each child's trust.
Billionaire Hedge Funds
